Among those, we validate the association between CFTR expression and lung adenocarcinoma in two independent cohorts and demonstrate experimentally that pharmacological stimulation of CFTR function at therapeutically relevant concentrations results in a dose-dependent inhibition of lung cancer cell proliferation. The gene discussed is CFTR; the disease is lung cancer.